Neuland Laboratories Ltd. Financials

09:49 Jun 19

Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
12275.00
+8.00 (+0.07%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Neuland Laboratories Ltd. Financials

Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
12275.00
+8.00 (+0.07%)
09:49 Jun 19
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

26/100
Expensive Valuation

Technical

48/100
Technically Neutral

Strength

5

Weakness

6

Opportunity

1

Threats

0

17.05 %

ROE %

11.93 %

ROA %

202.74

EPS

1,181.97

BVPS

17.61 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
936.91 951.08 1191.2 1558.58 1476.84
Operating Expenses +
790.09 808.45 919.35 1095.99 1153.57
Raw Material
439.66 437.55 487.74 632.43 574.81
Increase Decrease in Cost
-1.24 -15.41 -9.51 -55.14 12.83
Other Manufacturing Expense
120.29 131.36 135.56 156.51 0
Employee Cost
149.74 182.47 201.79 257.06 272
Miscellaneous Expenses
81.64 72.48 103.77 105.13 293.93
Operating Profit
146.82 142.63 271.85 462.59 323.27
Other Income
16.1 2.08 9.75 12.54 20.51
Depreciation
39.68 49.04 52.78 59.7 65.55
Interest
17.9 13.5 13.07 14 8.3
Profit before tax and exceptio..
105.33 82.16 215.75 401.44 269.93
Exceptional Items
0 0 0 0 76.4
PBT
105.33 82.16 215.75 401.44 346.33
Provision for Taxation
24.7 18.34 52.23 101.36 86.22
Net Profit
80.63 63.82 163.52 300.08 260.11
NET Profit after MI
80.63 63.82 163.52 300.08 260.11
EPS
62.85 49.74 127.45 233.89 202.74
Operating Profit Margin (%)
15.67 15 22.82 29.68 21.89
Net Profit Margin (%)
8.61 6.71 13.73 19.25 17.61

Neuland Laboratories Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 32.70 32.70 32.60 32.70 32.70
FII 22.10 23.90 26.50 25.70 24.40
MF 7.40 6.30 4.00 4.10 3.90
Others 4.00 3.10 2.70 2.70 3.10
Shareholder Shares Holding %
Download Our App On: